Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

TRANSENSE TECHNOLOGIES PLC Regulatory Filings 2019

Apr 30, 2019

7985_mrq_2019-04-30_ece7e8a7-20c8-4251-99b0-298883386e9a.html

Regulatory Filings

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 6229X

Transense Technologies PLC

30 April 2019

Transense Technologies plc

("Transense" or the "Company")

Holding(s) in Company

The Company received notification on 23 April 2019 that, following Fifth Admission as defined in the announcement dated 13 March 2019, Mr & Mrs Peter Lobbenberg are beneficially and non-beneficially interested in 968,979 ordinary shares of 10p each representing 5.94% of the Company's issued share capital.

For further information please visit www.transense.co.uk or contact:

Transense Technologies plc

Graham Storey, Chief Executive
Tel: +44 (0) 1869 238380
finnCap

Ed Frisby, Giles Rolls, Matthew Radley (Corporate Finance)

Tim Redfern, Manasa Patil (ECM)
Tel: +44 (0) 20 7220 0500
IFC Advisory

Tim Metcalfe, Graham Herring, Heather Armstrong
Tel: +44 (0) 20 3934 6630

About Transense Technologies

Based in Oxfordshire, UK, Transense has developed patent-protected sensor systems and supporting technology for use in a variety of diverse high growth markets. The Directors believe that Transense's Surface Acoustic Wave (SAW), wireless, battery-less, sensor systems offer advantages over legacy wireless sensor systems. Transense is targeting the transport and mining industries, and the global torque, temperature and pressure sensing markets, via its trading divisions, Translogik and SAWSense.

Transense's shares are admitted to trading on AIM (AIM: TRT).

www.transense.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

HOLEALLEDSXNEFF